REBECCA BOYLE: Open Payments
NPI 1316489800 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$776 in 55 payments from 11 companies in 2025. Trend: 2023 $58 · 2024 $1,475 · 2025 $776
Food & beverage: $776
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $236 |
| Indivior Inc. | 11 | $164 |
| Otsuka America Pharmaceutical, Inc. | 3 | $79 |
| Vanda Pharmaceuticals Inc. | 3 | $57 |
| Teva Pharmaceuticals USA, Inc. | 3 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Braeburn Inc. | 2 | $38 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Alkermes, Inc. | 1 | $31 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $24 |
Products named: VRAYLAR, SUBLOCADE, FANAPT, CAPLYTA, BRIXADI, Auvelity, UZEDY, VIVITROL.
Industry payments across OH — which companies pay providers there.
